Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 2,221,474 | 2,221,474 | 0 | $92.24M | $150.35M | 32.67% | +$58.11M |
| Alumis Inc. | 4,247,670 | 4,247,670 | 0 | $41.46M | $93.58M | 20.33% | +$52.12M |
| Centessa Pharmaceuticals plcADS | 1,364,019 | 1,364,019 | 0 | $34.11M | $54.18M | 11.77% | +$20.06M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 1,381,233 | 1,831,233 | +450,000 | $10.64M | $26.79M | 5.82% | +$16.16M |
| Denali Therapeutics Inc.(DNLI) | 1,000,000 | 1,209,971 | +209,971 | $16.51M | $23.23M | 5.05% | +$6.72M |
| Agios Pharmaceuticals, Inc.(AGIO) | 530,000 | 525,000 | -5,000 | $14.43M | $17.76M | 3.86% | +$3.33M |
| Verastem, Inc.(VSTM) | 3,135,120 | 3,146,631 | +11,511 | $24.20M | $16.68M | 3.62% | -$7.53M |
| Kymera Therapeutics, Inc.(KYMR) | 146,332 | 146,332 | 0 | $11.39M | $12.19M | 2.65% | +$801.9K |
| Minerva Neurosciences, Inc.(NERV) | 0 | 1,986,600 | +1,986,600 | $0 | $11.97M | 2.60% | +$11.97M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 315,913 | +315,913 | $0 | $10.02M | 2.18% | +$10.02M |
| AtaiBeckley Inc. | 0 | 2,750,000 | +2,750,000 | $0 | $9.73M | 2.12% | +$9.73M |
| Hinge Health, Inc.CL A(HNGE) | 135,000 | 220,400 | +85,400 | $6.27M | $8.50M | 1.85% | +$2.23M |
| Crinetics Pharmaceuticals, Inc. | 0 | 212,010 | +212,010 | $0 | $7.70M | 1.67% | +$7.70M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 1,445,783 | +1,445,783 | $0 | $5.99M | 1.30% | +$5.99M |
| Jade Biosciences, Inc. | 0 | 320,000 | +320,000 | $0 | $4.50M | 0.98% | +$4.50M |
| GH Research PLC(GHRS) | 0 | 315,492 | +315,492 | $0 | $4.44M | 0.96% | +$4.44M |
| Zura Bio LimitedCL A(ZURA) | 0 | 450,000 | +450,000 | $0 | $2.68M | 0.58% | +$2.68M |
| Atai Beckley N.V.SHS | 2,750,000 | 0 | -2,750,000 | $11.25M | $0 | — | -$11.25M |
| Natera, Inc.(NTRA) | 67,356 | 0 | -67,356 | $15.43M | $0 | — | -$15.43M |
| RAPT Therapeutics, Inc. | 1,562,500 | 0 | -1,562,500 | $52.92M | $0 | — | -$52.92M |